New Federal Initiatives to Enhance the Medical Treatment of Opioid Dependence

Overview

Journal Ann Intern Med

Specialty General Medicine

Date 2002 Oct 16

PMID 12379070

Citations 26

Authors

David A Fiellin

Patrick G OConnor

Affiliations

Soon will be listed here.

Abstract

Opioid dependence is a chronic relapsing medical condition with substantial health and societal complications. Recent federal initiatives are designed to enhance the medical treatment of patients with opioid dependence and will expand the role of internists in the care of these patients. These initiatives include a process for federal exemptions to allow for pharmacologic treatment in office settings, waivers for the use of new medications, and new rules governing the oversight and distribution of opioid agonist medications for maintenance treatment. This perspective describes these initiatives and their implications for internists.

Citing Articles

Building medication for opioid use disorder prescriber capacity during the opioid epidemic: Prescriber recruitment trends and methods.

Molfenter T, Jacobson N, Kim J, Horst J, Kim H, Madden L J Subst Use Addict Treat. 2023; 147:208975.

PMID: 36804353 PMC: 10833474. DOI: 10.1016/j.josat.2023.208975.

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.

Raleigh M, Peterson S, Laudenbach M, Baruffaldi F, Carroll F, Comer S PLoS One. 2017; 12(12):e0184876.

PMID: 29194445 PMC: 5711015. DOI: 10.1371/journal.pone.0184876.

Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.

McHugh R, Votaw V, Barlow D, Fitzmaurice G, Greenfield S, Weiss R Contemp Clin Trials. 2017; 60:105-112.

PMID: 28689852 PMC: 5553551. DOI: 10.1016/j.cct.2017.07.006.

Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.

Rieckmann T, Gideonse N, Risser A, DeVoe J, Abraham A J Behav Health Serv Res. 2017; 44(3):351-363.

PMID: 28488155 DOI: 10.1007/s11414-017-9553-z.

What the ID Clinician Needs to Know About Buprenorphine Treatment for Opioid Use Disorder.

Westlake A, Eisenberg M Open Forum Infect Dis. 2017; 4(1):ofw251.

PMID: 28480247 PMC: 5413994. DOI: 10.1093/ofid/ofw251.